Impact of Standardized Heart Failure Management Center Construction on the Management of Patients With Chronic Heart

Xiaoxia Guo1, Lele Jing1, Changlin Zhai1

  • 1Department of Cardiology, Affiliated Hospital of Jiaxing University, Jiaxing, China.

Clinical Cardiology
|January 9, 2025
PubMed

Insights

Establishing a standardized heart failure management center (SHFMC) significantly improved chronic heart failure (CHF) treatment, reducing mortality and readmissions. This highlights the center

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Heart failure (HF) poses a significant burden on human health and socioeconomic factors.
  • Non-standardized treatment approaches for HF necessitate structured management solutions.
  • Standardized Heart Failure Management Centers (SHFMC) aim to address these treatment inconsistencies.

Purpose of the Study:

  • To evaluate the impact of an SHFMC on the management and prognosis of patients with chronic heart failure (CHF).
  • To assess improvements in treatment standardization, long-term efficacy, mortality, and readmission rates post-SHFMC implementation.

Main Methods:

  • Retrospective analysis of the SHFMC database at Jiaxing First Hospital.
  • Comparison of 263 CHF patients, divided into Group A (pre-SHFMC, n=137) and Group B (post-SHFMC, n=126).
  • Analysis included baseline data, treatment standardization, long-term outcomes, 1-year mortality, and readmission rates.

Main Results:

  • Significant increase in the utilization of Angiotensin Receptor-Enkephalinase Inhibitors (ARNIs), Beta-blockers (β-Bs), and SGLT2 inhibitors in Group B.
  • Improved long-term outcomes, reduced readmission rates, and lower 1-year all-cause mortality observed in Group B.
  • Enhanced standardization of CHF treatment protocols following SHFMC establishment.

Conclusions:

  • The establishment of an SHFMC is associated with marked improvements in the standardization of CHF care.
  • SHFMC implementation led to better long-term patient outcomes, including increased survival rates and decreased readmissions.
  • Standardized management centers are crucial for optimizing CHF patient care and reducing healthcare burdens.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
314
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
559
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338